BioAge Labs, Inc. (BIOA)
8.06
-0.03
(-0.37%)
USD |
NASDAQ |
Sep 18, 16:00
8.06
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Cash from Operations (Quarterly) : -19.26M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.26M |
| March 31, 2026 | -24.05M |
| December 31, 2025 | -28.25M |
| September 30, 2025 | -16.04M |
| June 30, 2025 | -19.97M |
| March 31, 2025 | -17.36M |
| December 31, 2024 | -5.138M |
| Date | Value |
|---|---|
| September 30, 2024 | -14.93M |
| June 30, 2024 | -15.78M |
| March 31, 2024 | -15.67M |
| December 31, 2023 | -8.503M |
| September 30, 2023 | -7.763M |
| June 30, 2023 | -11.09M |
| March 31, 2023 | -10.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly & Co. | 10.69B |
| Pfizer Inc. | 835.00M |
| Oramed Pharmaceuticals, Inc. | -0.2799M |
| Liquidia Corp. | 80.24M |
| Neumora Therapeutics, Inc. | -39.97M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -164.51M |
| Cash from Financing (Quarterly) | 15.97M |
| Free Cash Flow | -88.09M |
| Free Cash Flow Per Share (Quarterly) | -0.4369 |
| Free Cash Flow to Equity (Quarterly) | -18.39M |
| Free Cash Flow to Firm (Quarterly) | -19.59M |
| Free Cash Flow Yield | -27.45% |